NCT06402695 Observational Study on GEP-and Pulm-NET Treated at FPG
| NCT ID | NCT06402695 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Neuroendocrine Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 650 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 650 participants in total. It began in 2023-09-15 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
Eligibility Criteria
Inclusion Criteria: * histological diagnosis of gastroenteropancreatic or pulmonary NET * age ≥ 18 years; * radiological evidence of resectable/locally advanced/metastatic disease; * signing of informed consent; * at least one visit following the first oncological visit. Exclusion Criteria: * absence of clinical data that allow adequate definition of survival (primary endpoint of the study); * absence of histological diagnosis; * failure to sign the informed consent.
Contact & Investigator
Giovanni Schinzari
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT06402695 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Neuroendocrine Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06402695 currently recruiting?
Yes, NCT06402695 is actively recruiting participants. Contact the research team at mariagrazia.maratta@guest.policlinicogemelli.it for enrollment information.
Where is the NCT06402695 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06402695 clinical trial?
NCT06402695 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Giovanni Schinzari at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 650 participants.